MediGene AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MediGene AG with three other
miscellaneous service companies in Europe:
sales of 9.86 million Euro [US$11.54 million]
GW Pharmaceuticals PLC
of the United Kingdom
(£8.24 million [US$11.00 million]
of which 94%
was Commercial), and
based in Belgium
(9.06 million Euro [US$10.59 million]
MediGene AG reported sales of 10.30 million Euro (US$12.04 million)
December of 2017.
increase of 39.4%
versus 2016, when the company's sales were 7.38 million Euro.
Sales of Immunotherapies saw an increase
that was more than double the company's growth rate: sales were up
364.0% in 2017, from
1.05 million Euro to 4.89 million Euro.
Not all segments of MediGene AG experienced an increase in sales in 2017:
sales of Outlincencedproducts fell 54.5% to 2.79 million Euro.